DCM
CINC

Driehaus Capital Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Driehaus Capital Management’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-354,729
Closed -$4.36M – 458
2022
Q4 		$4.36M Sell
354,729
-99,186
-22% -$2.36M 0.07% 270
2022
Q3 		$14.9M Sell
453,915
-33,364
-7% -$943K 0.23% 138
2022
Q2 		$9.18M Buy
+487,279
New +$9.33M 0.15% 208

Driehaus Capital Management's CINC Position: Q1 2023 in Review

Driehaus Capital Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 354,729 shares — an estimated $4.36M sold.

Driehaus Capital Management first reported a position in CINC in Q2 2022 and held it in 3 quarters. The position peaked at $14.9M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Driehaus Capital Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Driehaus Capital Management sold 354,729 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $4.36M.
  • Driehaus Capital Management first reported a position in CinCor Pharma, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Driehaus Capital Management's CinCor Pharma, Inc. Common Stock position peaked at $14.9M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Driehaus Capital Management's 13F filing for Q1 2023, filed 15 May 2023.